https://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencySun, 16 Jun 2024 12:13:08 +0200Thu, 08 Feb 2024 11:34:00 +0100https://www.ema.europa.eu/en/medicines/human/EPAR/omjjaraHuman medicines European public assessment report (EPAR): Omjjara, momelotinib, Date of authorisation: 25/01/2024, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/omjjaraThu, 08 Feb 2024 11:34:00 +0100Human medicinehttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5768-en.pdfOmjjara : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5768-en.pdfThu, 08 Feb 2024 11:23:16 +0100Human medicine